このアイテムのアクセス数: 37

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
j.mmcr.2024.100689.pdf3.07 MBAdobe PDF見る/開く
タイトル: Uncommon concurrent pulmonary infections: Aspergillus fumigatus and Lomentospora prolificans in an Anti-MDA5 antibody-positive dermatomyositis patient
著者: Fukumura, Maaya
Hiwa, Ryosuke
Yukawa, Satomi
Tsuchido, Yasuhiro  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0003-1306-3652 (unconfirmed)
Yoshifuji, Hajime
Morinobu, Akio
著者名の別形: 福村, 麻綾
日和, 良介
湯川, 理己
土戸, 康弘
吉藤, 元
森信, 暁雄
キーワード: Anti-MDA5 antibody-positive dermatomyositis
Rapidly progressive interstitial lung disease
Aspergillus fumigatus
Lomentospora prolificans
発行日: Mar-2025
出版者: Elsevier BV
International Society for Human and Animal Mycology
誌名: Medical Mycology Case Reports
巻: 47
論文番号: 100689
抄録: A 59-year-old female with anti-MDA5 antibody-positive dermatomyositis was treated with prednisolone, tacrolimus, cyclophosphamide, tofacitinib, and plasma exchange. Five months post-treatment, elevated β-D-glucan levels and a pulmonary shadow on CT were noted. Aspergillus fumigatus was identified, leading to voriconazole initiation. A new pulmonary cavity lesion later revealed Lomentospora prolificans. Considering voriconazole resistance, terbinafine was added, resulting in clinical improvement. Vigilant infection monitoring is crucial during anti-MDA5 antibody-positive dermatomyositis treatment.
著作権等: © 2024 The Authors. Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.
This is an open access article under the CC BY license.
URI: http://hdl.handle.net/2433/291656
DOI(出版社版): 10.1016/j.mmcr.2024.100689
PubMed ID: 39760058
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons